Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

A veteran went into rehab in Sun City Center after a knee replacement and came out with a more than $19,000 bill.

Diabetes and weight-loss drugs drugs like Ozempic and Wegovy have become increasingly popular — and are incredibly expensive.

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

Surgeons are removing up to 10 kilograms of excess skin from patients who have lost major amounts of weight, amid a booming ...

U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could ...

The FDA recently announced that Novo Nordisk’s semaglutide GLP-1 medication (Ozempic and Wegovy) is no longer in short supply ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...